Notice is hereby given that in pursuance of SEBI (PIT), Regulations, 2015 and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed the stock exchanges that its trading window for dealing in company securities will remain closed from July 01, 2025 until 48 hours after the public announcement of unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). The closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider trading code. All promoters, designated persons, and connected persons are barred from trading in the company's shares during this period, either directly or indirectly. The exact date of the board meeting to approve the Q1 results will be communicated later.
This is a routine regulatory filing and not a material event for shareholders. It signals that the company is preparing to announce Q1 FY26 earnings in early July; investors should expect upcoming financial results that could influence short-term stock movement. No insider buying or selling transactions are disclosed in this filing.